Acute Liver Failure (ALF): Symptoms, Red Flags & Urgent Referral
Encephalopathy and coagulopathy on a short timeline—etiology workup, critical care bundles, referral triggers, and what to chart for the liver team.
Featured snippet
Acute liver failure (ALF) is a rare syndrome of rapid hepatocellular necrosis producing coagulopathy (typically INR ≥1.5) and hepatic encephalopathy in someone without underlying cirrhosis, usually within weeks of a new insult.
Management is time-critical: identify the trigger (commonly acetaminophen toxicity or viral hepatitis), start resuscitation and antidotes early, support organs in ICU, and activate specialist pathways before cerebral edema and multi-organ failure narrow transplant options.
- Think ALF when jaundice, bleeding tendency, and neuropsychiatric change evolve quickly in a previously well adult—this is not routine decompensated cirrhosis unless imaging/history proves chronic disease.
- Acetaminophen remains a dominant cause in many Western cohorts; early intravenous acetylcysteine and toxicology engagement save parenchyma even when ingestion history is unclear.
- Labs trending INR, liver enzymes, ammonia, lactate, glucose, and renal indices should be packaged with medication/supplement timelines for hepatology.
- Neurological change can outpace paperwork—serial GCS, seizure precautions, and early ICU review protect airway and intracranial pressure.
- Transplant decisions use structured criteria and center expertise; nursing documentation of neuro trend, pressor needs, urine output, and transfusion response materially informs referral calls.
⚡ Quick Facts
💡 Clinical Pearl
Regenerative nodular liver on CT can mimic cirrhosis. In hyperacute injury the liver sometimes looks “cirrhotic” radiologically while the history remains short—do not let imaging alone stop the ALF pathway if coagulopathy and encephalopathy align.
📋 Contents
What is Acute Liver Failure?
Acute liver failure describes a severe loss of synthetic and detoxification capacity over days to a few months in a person who did not previously carry a diagnosis of cirrhosis. Hepatocytes die faster than the organ can regenerate, so clotting factors fall, ammonia and other neurotoxins rise, glucose regulation falters, and inflammatory cascades injure neighbouring organs. Because presentation straddles emergency medicine, gastroenterology, and critical care, the initial nursing picture is often shock, bleeding risk, rapidly shifting mental status, and lab instability rather than a “stable ward liver patient.”
Pathophysiology is etiology-specific but converges on massive inflammation, endothelial dysfunction, and susceptibility to sepsis. Cerebral edema, formerly a dominant killer, now competes with infection, acute kidney injury, and circulatory collapse as determinants of who survives to transplant or native recovery. The bedside implication is simple: every hour of diagnostic delay narrows the window for antidote therapy, targeted antimicrobials, and referral for organ support.
Tempo, grades, transplant scores
Specialists classify ALF by the interval from jaundice to encephalopathy (hyperacute, acute, subacute) because tempo tracks complications—hyperacute courses may have soaring transaminases with later bilirubin rise, while subacute patterns can look “cholestatic” yet still cross transplant thresholds. Clinical teams also stage confusion, asterixis, and agitation using West Haven criteria to communicate ICU handoffs clearly.
King’s College criteria (and contemporaneous scores such as MELD-based derivatives) help hepatologists triage transplantation—they are not bedside calculators for nursing staff to operationalize alone. Your role is to supply granular trends: pressor dose changes, hourly urine via intake and output monitoring, lactate direction, transfusion timing, and precisely witnessed neuro exams so consultants can apply those models faithfully.
| Category | Jaundice → encephalopathy | Clinical nuance |
|---|---|---|
| Hyperacute | ≤7 days | Often massive transaminase elevation; cerebral edema risk emphasized in teaching—still monitor every neuro change closely. |
| Acute | 8–28 days | Intermediate course; infections and hemodynamic instability remain drivers. |
| Subacute | 29 days–12 weeks | May resemble cholestatic injury; transplant consideration can arise even when enzymes are falling if synthetic failure progresses. |
On a small screen, swipe or scroll sideways to see the full table.
- New somnolence, combative delirium, or sudden pupillary asymmetry after a hyper-acute hepatitis picture—activate ICU neuro-protective pathways.
- Profound metabolic acidosis, lactate elevation on serial draws, or escalating vasopressor need despite fluid—think multi-organ failure and expedite liaison.
- Hypoglycemia without explanation—glycogenolysis fails early; pair point-of-care glucose checks with unit policies for confirmatory lab sampling when mental status changes.
Symptoms
Early complaints are easy to dismiss—nausea, emesis, vague right upper-quadrant discomfort, malaise, and low-grade fever overlap with countless viral illnesses. As synthetic failure advances, jaundice deepens, bruising appears without trauma, and mentation slips from sleep–wake inversion to frank disorientation.
A classic hyperacute acetaminophen injury may show sky-high aminotransferases initially with comparatively modest bilirubin, whereas subacute autoimmune or drug patterns may invert that ratio. Seizures, posturing, or sudden hypertension with bradycardia imply critical neurology involvement—pair every change with a contemporaneous Glasgow Coma Scale score and stimulus response description.
Causes and Risk Factors
Geography and population dictate probability tables. In many Western cohorts intentional or staggered acetaminophen overdoses dominate; always involve poison centers early, even when the history is unreliable. Viral etiologies such as hepatitis A and hepatitis B remain core differentials worldwide; obtain appropriate serologies and PCR strategies per protocol.
Drug-induced injury spans isoniazid, antiepileptics, herbal products, and “bodybuilding” supplements—build a granular timeline rather than a one-line allergy list. Autoimmune hepatitis can masquerade as cryptogenic ALF if serologies lag, while alcoholic hepatitis historically argues against isolated classic ALF if long-standing drinking implies fibrosis—still communicate the picture accurately and let hepatology reconcile overlap syndromes.
How is it Diagnosed?
Clinical assessment
Triage hinges on detecting encephalopathy in the setting of new jaundice or biochemistry that reveals synthetic failure. Maintain honest neuro documentation: orientation domains, asterixis, focal deficits, and any postictal features after suspected seizure.
Laboratory investigations
Repeat a broad panel frequently enough to expose trajectory—not a single morning snapshot. Pair liver function tests with INR, venous or arterial acid–base status, ammonia (interpret cautiously), lactate, glucose, and renal filtration markers such as eGFR alongside serum chemistries.
Imaging
Ultrasound or CT clarifies vascular patency, nodular regenerative change versus cirrhosis, and ascites burden. Imaging complements—but never replaces—bedside synthesis when referral hinges on tempo.
Special studies
Liver biopsy is selective because coagulopathy raises procedural hazard; when pursued, it settles autoimmune or infiltrative questions after safer screens fail.
Clinical decision flow
- Stabilize first—two large-bore lines, airway assessment, targeted resuscitation, early blood product planning working with hematology/hepatology thresholds.
- Secure diagnosis kit—draw viral, autoimmune, and metabolic bundles before empiric therapy muddies interpretation where feasible.
- Start antidotes—IV acetylcysteine for confirmed or strongly suspected acetaminophen toxicity per poison-center dosing; continue non-paracetamol regimens only if your network’s policy supports them.
- Neuroprotect—elevate head of bed, avoid unnecessary sedatives, treat seizures aggressively, involve ICU for intracranial pressure strategies when indicated.
- Escalate early—telephone the liver transplant center when King’s or equivalent thresholds approach; bed availability should never delay the first conversation.
Differential Diagnoses
- Sepsis or hypoperfusion (“shock liver”) with modest enzyme rise—usually without deep encephalopathy unless multi-organ failure supervenes.
- Budd-Chiari or veno-occlusive disease—imaging and thrombophilia workup pivot management toward anticoagulation or decompression.
- Cirrhosis with acute-on-chronic decompensation—clinical context and chronic stigmata point away from pure ALF even if acute injury coexists.
- Reye-like metabolic crises or Wilson disease in younger cohorts—specialized metabolic labs and family history matter.
Treatment Options
First-line management
ICU-level care is the default for encephalopathy beyond minimal stages, refractory hypotension, or rising INR despite therapy. Airway protection precedes aspiration catastrophe. Empiric glucose and thiamine align with local malnutrition policies while monitoring for cerebral edema triggers such as aggressive hypotonic fluids.
Reduce gut-derived ammonia using bowel strategies cautiously—lactulose or rifaximin may appear in orders, and nurses administering lactulose should tally stool frequency to avoid over-diuresis and electrolyte wasting.
Second-line / advanced support
Renal replacement therapy bridges ammonia control and acid–base balance; plasma exchange or liver-assist devices remain center-dependent. Vasopressors, targeted antibiotics after cultures, and stress-ulcer prophylaxis decisions follow ICU protocols.
Transplantation
Orthotopic liver transplant remains definitive when native recovery is unlikely; coordinators need transparent documentation of every deterioration milestone.
Special populations
Pregnancy-associated failure and pediatric metabolic disorders invoke maternal–fetal or PICU pathways—defer specifics to subspecialists but maintain aggressive glucose and neuro checks in both cohorts.
Clinical Practice Considerations
- Repeat labs on a schedule your hepatology team names—typically q6–12h early—rather than “daily routine” patterns designed for stable wards.
- Medication reconciliation must include OTC combination analgesics, recent antibiotics, and non-prescribed supplements; hold hepatotoxins pending review.
- Vascular access planning anticipates central line care, large-bore peripheral access, and strict line hygiene because bacteremia worsens encephalopathy.
- Coordinate safe transport to MRI or angiography when needed—critically ill patients need airway-ready escorts.
- Failure signal: rising ammonia plus deepening coma despite lactulose, progressive oliguria, or refractory hypotension—all warrant immediate senior notification.
Possible Complications
Cerebral edema and intracranial hypertension, pulmonary edema, ARDS, gastrointestinal bleeding from stress-related mucosal injury or coagulopathy, renal failure requiring continuous circuits, and nosocomial infections each compound mortality. Continuous cardiac monitoring helps catch arrhythmias driven by acid–base chaos even before clinicians round.
Prevention
Clinician-facing prevention centers on safe prescribing of acetaminophen, monitoring for TB-drug hepatotoxicity, timely vaccination counseling for viral hepatitis risks, and reconciling polypharmacy in patients with intercurrent alcohol use. Teach ward teams to recognize early overdose presentations so antidote clocks start sooner.
Prognosis and Outlook
Mortality remains substantial without transplant; acetaminophen cohorts that receive prompt NAC and ICU support fare better than cryptogenic presentations discovered late. Native liver recovery still occurs—expect teams to repeat prognostic scoring rather than anchoring to day-one impressions alone.
In Clinical Practice…
Nursing staff often detect subtle asterixis or word-finding difficulty before scores formally change—speak up in safety huddles. Families may minimize alcohol or herbal use; interpreter services should join history-taking early. When transferring to a quaternary center, package imaging disks, serial labs, and a clear encephalopathy timeline.
Bedside monitoring checklist
- Neuro checks each shift minimum and with every medication change affecting mentation.
- Point-of-care glucose with any neuro fluctuation.
- Strict I&O with cumulative balance communicated verbally at handover.
- Line audits and blood culture timing documented when febrile.
- Arterial blood gas sampling paired with ventilation changes to track acidosis.
When to Seek Emergency Care
Activate emergency pathways for sudden coma, repeated seizures, hematemesis with hemodynamic instability, SpO₂ failure despite supplemental oxygen, refractory hypotension, or any patient with known ALF who develops an acute pop in ICP symptoms such as pupil inequality.
- Objective: lactate uptrend, falling platelets, oliguria despite boluses, new metabolic acidemia on VBG/ABG.
- Escalate to ICU fellow/attending when pressors start or airway equipment enters the room prophylactically.
- Call hepatology/transplant on-call when referral criteria discussed—do not wait for “conference day.”
Nursing management
Pre-transfer / resuscitation phase
Focus on visible stability: secure oxygen, establish monitoring, obtain baseline weight, label all blood tubes with exact collection times for trend tables.
ICU phase
Cluster care when intracranial pressure is tenuous; pad bed rails, maintain seizure precautions, and guard against unnecessary stimulation.
Education & evaluation
Update families honestly about transplantation listing discussions; evaluate understanding of visitation limits during procedures. Use teach-back on visiting policies, hand hygiene, and escalation words such as “neuro change” so relatives become safety partners.
NCLEX practice questions
These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and cloze drops on the topic of acute liver failure recognition (coagulopathy + encephalopathy + jaundice <26 weeks), N-acetylcysteine for paracetamol toxicity and King’s College transplant criteria.
Unfolding case (Questions 1–3): Ms. T., 28, presents 36 hours after an intentional ingestion of approximately 30 g of paracetamol with a co-ingestion of alcohol. Day 3 of admission: she is now jaundiced and confused (asterixis on exam), INR 3.6 (no anticoagulant), ALT 6800 U/L, creatinine 180 µmol/L, lactate 3.8 mmol/L, glucose 3.0 mmol/L. NAC was started at 28 hours; the regional liver transplant centre has been called.
Answer key & rationale
How is acute liver failure defined at the bedside?
Classic ALF pairs coagulopathy (often INR ≥1.5) with hepatic encephalopathy in someone without known cirrhosis and with illness duration under roughly 26 weeks—local hepatology wording may add nuances.
When should intravenous N-acetylcysteine be considered?
Start early for suspected or confirmed acetaminophen-mediated injury using poison-service nomograms; many centres extend NAC to non-paracetamol ALF per hepatology discretion—follow your formulary.
Does rising ammonia always mirror encephalopathy grade?
No—values can be misleadingly low or high relative to exam; trend the patient, not a single ammonia.
Why can patients both bleed and thrombose?
ALF disrupts pro- and anti-coagulant proteins simultaneously—“rebalanced” hemostasis means consult-driven transfusion rather than reflex plasma.
How does renal failure change management?
Oliguria worsens acidosis and encephalopathy; align CRRT timing with nephrology/hepatology and document hourly balances.
What triggers an urgent transplant call?
Rapid neuro decline, deepening acidemia, escalating vasopressors, and King’s criteria positives in expert hands—communicate objective trends, not impressions alone.
Which drug classes deserve immediate scrutiny?
Anti-TB therapy, anticonvulsants, high-dose amoxicillin–clavulanate contexts, herbals, and novel supplements—timeline every exposure.
What nursing cues suggest intracranial hypertension?
Pupillary asymmetry, sustained hypertension with relative bradycardia, posturing, or abrupt loss of arousal—summon ICU leadership immediately.
- American Association for the Study of Liver Diseases. Management of Acute Liver Failure (practice guidance overview).aasld.org/practice-guidelines/management-acute-liver-failure
- StatPearls [Internet]. Acute Liver Failure.ncbi.nlm.nih.gov/books/NBK482374
- LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Acute Liver Failure associated with drugs.ncbi.nlm.nih.gov/books/NBK548171
- Stravitz RT, Lee WM; Acute liver failure. Lancet. 2019.pubmed.ncbi.nlm.nih.gov/31498101
- Aziz R, Price J, Agarwal B. Management of acute liver failure in intensive care. BJA Educ. 2021 (PMC).pmc.ncbi.nlm.nih.gov/articles/PMC7892353
- Maiwall R, et al. Acute liver failure. Lancet. 2024.pubmed.ncbi.nlm.nih.gov/39098320
- Centers for Disease Control and Prevention. Hepatitis B.cdc.gov/hepatitis/hbv/index.htm
- Centers for Disease Control and Prevention. Hepatitis A.cdc.gov/hepatitis/hav/index.htm
- World Health Organization. Hepatitis B fact sheet.who.int/hepatitis-b fact sheet
- National Institute of Diabetes and Digestive and Kidney Diseases. Research news on acetaminophen combination products and acute liver failure context.niddk.nih.gov/news/archive/2023/limits-acetaminophen…
- UK Medicines and Healthcare products Regulatory Agency (via GOV.UK). Drug Safety Update: treating paracetamol overdose with IV acetylcysteine.gov.uk/drug-safety-update/paracetamol-acetylcysteine
- NICE Clinical Knowledge Summaries. Analgesia – mild-to-moderate pain: paracetamol poisoning context link (management section).cks.nice.org.uk/…/paracetamol
